Itacitinib in haploidentical hematopoietic cell transplantation, diagnosis and management of purpura fulminans, and lack of evidence for sickle cell crisis-associated mortality in individuals with sickle cell trait

In this week's episode, we’ll learn more about using itacitinib for the prevention of graft vs host disease in haploidentical transplants, diagnosis and management of purpura fulminans, and results of a systematic review seeking evidence for sickle cell crisis-associated mortality in individuals with sickle cell trait.

 
Featured Articles:

• Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
• How I diagnose and treat acute infection–associated purpura fulminans
• Sickle cell trait does not cause “sickle cell crisis” leading to exertion-related death: a systematic review